Adlai Nortye News, Adlai Nortye Quote, ANL Quote

Adlai Nortye (NQ:ANL) Delayed: 15.09 +0.40 (2.72%)

Prev. Close

$14.69

Today 6M 1Y 5Y

Open

$14.97

52 Wk High

$22.89

52 Wk Low

$1.85

Day High

$15.78

Day Low

$14.70

P/E

N/A

EPS

$-0.06

Volume

318,222

Friends, Peers and Foes (?): BNAI, DBRG SOPA (more...)

ALERTS | RSS

Sep 10, 2026 06:10 AM Jefferies Starts Adlai Nortye Ltd. (ANL) at Buy
Sep 8, 2026 07:01 AM Adlai Nortye doses first patient in AN4035 global Phase I trial
Sep 8, 2026 07:00 AM Adlai Nortye Announces First Patient Dosed in Australia and U.S. FDA IND Clearance for AN4035, a First-in-Class Pan-RAS(ON) Inhibitor-Based ADC
Sep 8, 2026 06:36 AM Lucid Capital Markets Starts Adlai Nortye Ltd. (ANL) at Buy
Aug 26, 2026 04:28 PM Form 4 Adlai Nortye Group Ltd. For: Aug 24 Filed by: Ye Xiaofeng
Aug 19, 2026 08:30 AM Form 6-K Adlai Nortye Ltd. For: Aug 19
Aug 14, 2026 04:49 PM Form SCHEDULE 13G/A Adlai Nortye Ltd. Filed by: Venrock Healthcare Capital Partners III, L.P.
Aug 14, 2026 02:00 PM Form SCHEDULE 13G/A Adlai Nortye Ltd. Filed by: Cormorant Asset Management, LP
Aug 14, 2026 07:23 AM Form 6-K Adlai Nortye Ltd. For: Aug 14
Aug 14, 2026 07:00 AM Adlai Nortye Ltd. Reports Unaudited First Half 2026 Financial Results and Highlights Recent Operational Progress

Entities mentioned with ANL

View All Entities